Credit Agricole’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-28
Closed -$3K 1149
2017
Q3
$3K Sell
28
-2,863
-99% -$312K ﹤0.01% 1423
2017
Q2
$324K Buy
2,891
+346
+14% +$39.1K ﹤0.01% 1252
2017
Q1
$297K Buy
2,545
+1,441
+131% +$159K ﹤0.01% 1489
2016
Q4
$116K Buy
1,104
+1,076
+3,843% +$113K ﹤0.01% 1381
2016
Q3
$3K Sell
28
-2,841
-99% -$376K ﹤0.01% 1597
2016
Q2
$418K Sell
2,869
-1,907
-40% -$270K ﹤0.01% 1218
2016
Q1
$684K Buy
4,776
+4,742
+13,947% +$674K ﹤0.01% 1002
2015
Q4
$5K Sell
34
-66
-66% -$9.64K ﹤0.01% 1407
2015
Q3
$14K Buy
+100
New +$14K ﹤0.01% 1437

Other funds holding TARO

Credit Agricole's TARO Position: Q4 2017 in Review

Credit Agricole sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 28 shares — an estimated $3K sold.

Credit Agricole first reported a position in TARO in Q3 2015 and held it in 9 quarters. The position peaked at $684K in Q1 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • Credit Agricole reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • Credit Agricole sold 28 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $3K.
  • Credit Agricole first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 9 quarters.
  • Credit Agricole's Taro Pharmaceutical Industries Ltd. position peaked at $684K in Q1 2016.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.